Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
53.59 EUR | -0.17% |
|
-1.40% | +0.98% |
10:21am | SIEMENS HEALTHINEERS : UBS remains its Buy rating | ZD |
06-28 | German Shares Advance Ahead of French Snap Elections | MT |
Strengths
- The company's profit outlook over the next few years is a strong asset.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company is in debt and has limited leeway for investment
- With an expected P/E ratio at 29.84 and 23.51 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- With an enterprise value anticipated at 3.16 times the sales for the current fiscal year, the company turns out to be overvalued.
- The company appears highly valued given the size of its balance sheet.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+0.98% | 64.26B | - | ||
+0.59% | 204B | B | ||
+3.92% | 178B | B- | ||
+30.07% | 156B | B- | ||
+32.42% | 113B | A- | ||
+19.65% | 54.98B | B+ | ||
-1.86% | 47.44B | - | B+ | |
-9.53% | 36.7B | A | ||
-1.28% | 34.84B | - | - | |
+10.07% | 27.82B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- SHL Stock
- SHL Stock
- Ratings Siemens Healthineers AG